News Focus
News Focus
icon url

vator

03/09/22 1:26 PM

#449970 RE: Maverick0408 #449968

After approval the people at the helm for operations minus research and testing is Advent. NWBO will be the money collection phase. Advent is showing they are capable of setting up the facility. I would guess they know a thing or two about running the facility.
icon url

Poor Man -

03/09/22 2:21 PM

#449984 RE: Maverick0408 #449968

Or at least wait until the ASM becomes bingo night.
icon url

ATLnsider

03/09/22 2:48 PM

#449993 RE: Maverick0408 #449968

I disagree Maverick0408, if Linda Powers and the rest of the NWBio management team, can continue to execute on the following:

(1) successfully navigate through all the challenges and obstacles inherent in completing a multi-national Phase III clinical trial, in 4 different countries (US, UK, Canada, Germany) for 1 of the most difficult to treat diseases in the world, and where dozens of other large & small pharmaceutical companies, who have tried since 2005 have failed;

(2) overcome the torrrent of resistance from legal and illegal shorts, hedge funds, and other who have been actively and aggressively trying to stop NWBio from succeeding;

(3) overcome the barrage of coordinated and concerted disinformation, misinformation and outright lies about NWBio and the DCVax vaccine platform, all across social media, message boards, chat roooms, etc;

(4) finally, release positive DCVax-L TLD and journal article; and

(5) Obtain regulatory approvals for DCVax-L in the US, UK, Canada, Germany and the rest of the EU.

Others may hop off this train after TLD and a nice pop in NWBO share price. There is nothing wrong with that, and that is totally their decision.

I will continue to ride with this management team beyond this first phase of success (regulatory approval in the US, UK, Canada, Germany and the rest of the EU), until the facts on the ground tells me that they have stopped executing their additional business plans (DCVax Direct positive trials & approvals, DCVax-L approvals for other solid tumor cancers, etc.